Topic
obesity-drugs
5 stories related to this topic, newest first.
rediff.comscience7 days ago
Employers Route Obesity Drug Access Through Telehealth Firms That Add Extra Requirements
Workers report being steered to telehealth providers that require additional steps before approving GLP-1 prescriptions, even when primary care doctors have already prescribed the drugs.
cnbc.comscience21 days ago
Medicare to Cover Wegovy and Zepbound for Obesity Treatment at $50 Monthly Copay Starting July 1
The temporary GLP-1 Bridge program will run through December 2027. Taxpayers will cover most costs for millions of new patients.
Semaforworld31 days ago
Novo Nordisk Loses Canadian Patent on Ozempic
Generic versions of Ozempic became available in Canada this week after Novo Nordisk did not renew its patent. The company said its intellectual property decisions are made at the global level.
medpagetoday.comscience48 days ago
GLP-1 Obesity Drugs Generate Higher R&D Returns Than Oncology
Obesity treatments have become the leading driver of pharmaceutical research and development gains, surpassing oncology. A Deloitte partner highlighted concentration risks for companies reliant on these drugs. Plus-size model Ashley Graham described the trend as disheartening for…
ilounge.comscience52 days ago
Eli Lilly Reports Strong Q1 2026 Earnings and Raises Full-Year Guidance
Eli Lilly reported first-quarter 2026 earnings and revenue that exceeded analyst estimates, driven by sales of its drugs Zepbound and Mounjaro. The company raised its full-year sales outlook by $2 billion and increased its adjusted profit guidance. Demand for these treatments con…